News

According to GSK and Valeant, EC has given its approval on the basis of the results from pivotal Phase III studies 1 and 2 and Study 205, a

Under the collaboration agreement, Asterand and 5AM Solutions are expected to share the development costs to build software offering a standardized solution to identify, annotate and distribute human

CTP-499, invented using Concert’s DCE Platform (deuterated chemical entity platform), is a potential first-in-class treatment for chronic kidney disease. It is a deuterium containing new chemical entity which

The systematic and indication-specific determination of autoantibody patterns will serve as a powerful basis to address hitherto unmet diagnostic needs. UNIarray serves as platform for the development of

The trial was designed to demonstrate survival benefit for patients treated with PHP after 28 days compared to placebo (+ standard care), and at day 60 and day

The company’s gross profit for the fourth quarter was $10.5m, an increase of 25.2% compared to $8.4m in 2009. Lotus Pharma‘s revenues for the fiscal year ended 31

Soren Stroh, founder and previous owner, continues his role as CEO of aCROnordic for Nordic region. aCROnordic is a provider of drug and medical device development services to

The company is constructing a new 60,000sqft building adjacent to existing buildings to create a Slough campus. Lonza‘s Slough site is into developing and manufacturing antibodies and therapeutic

Headquartered in New Jersey, JHP Pharma is a provider of contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.